Either the IRB is technically not approved despite the study being registered. I'm no expert and it is entirely possible that the study can be registered before the IRB is officially approved. This same thing happened with BTH/CF if you recall. The study was registered but the press release took a few weeks.
Another possibility is that the company is planning to put out a combined press release with other news that they are waiting on. For example, recall last week that the company announced a non-binding term sheet with Alumina Partners? Perhaps they are finalizing the definitive legal docs and plan to announce the IRB along with the signing of those docs.
In my opinion, the company has been quite forthright in news disclosure so I'm not concerned about the lack of news on the IRB or transparency in general. I would take this as an opportunity for anyone still looking to pick up cheap shares. I don't expect this will stay below C$0.10 for much longer once the news does get announced. That's just my opinion.
JB
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM